These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 32520690

  • 1. Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies.
    Hadda TB, Deniz FSS, Orhan IE, Zgou H, Rauf A, Mabkhot YN, Bennani B, Emam DR, Kheder NA, Asayari A, Muhsinah AB, Maalik A.
    Med Chem; 2021; 17(8):834-843. PubMed ID: 32520690
    [Abstract] [Full Text] [Related]

  • 2. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB, Talhi O, Silva ASM, Senol FS, Orhan IE, Rauf A, Mabkhot YN, Bachari K, Warad I, Farghaly TA, Althagafi II, Mubarak MS.
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [Abstract] [Full Text] [Related]

  • 3. Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives.
    Hadda TB, Rauf A, Zgou H, Senol FS, Orhan IE, Mabkhot YN, Althagafi II, Farghaly TA, Alterary S.
    Mini Rev Med Chem; 2019; 19(8):688-705. PubMed ID: 30387392
    [Abstract] [Full Text] [Related]

  • 4. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
    Gálvez J, Polo S, Insuasty B, Gutiérrez M, Cáceres D, Alzate-Morales JH, De-la-Torre P, Quiroga J.
    Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
    [Abstract] [Full Text] [Related]

  • 5. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A, Zehra ST, Shah SJ, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J.
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [Abstract] [Full Text] [Related]

  • 6. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H, Jiang Y, Zhan J, Sun Y.
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [Abstract] [Full Text] [Related]

  • 7. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Kovaleva NV, Yu Astakhova T, Boltneva NP, Rudakova EV, Serebryakova OG, Proshin AN, Serkov IV, Trofimova TP, Tafeenko VA, Radchenko EV, Palyulin VA, Fisenko VP, Korábečný J, Soukup O, Richardson RJ.
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [Abstract] [Full Text] [Related]

  • 8. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 9. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ.
    Molecules; 2022 Feb 04; 27(3):. PubMed ID: 35164325
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S, Ghobadian R, Mahdavi M, Nadri H, Moradi A, Akbarzadeh T, Najafi Z, Sharifzadeh M, Edraki N, Moghadam FH, Amini M.
    Daru; 2020 Dec 04; 28(2):463-477. PubMed ID: 32372339
    [Abstract] [Full Text] [Related]

  • 11. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A, Saini V, Meena P, Tiwari M.
    Bioorg Med Chem; 2015 Oct 01; 23(19):6389-403. PubMed ID: 26337018
    [Abstract] [Full Text] [Related]

  • 12. Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
    Munir R, Zia-Ur-Rehman M, Murtaza S, Zaib S, Javid N, Awan SJ, Iftikhar K, Athar MM, Khan I.
    Molecules; 2021 Jan 27; 26(3):. PubMed ID: 33513837
    [Abstract] [Full Text] [Related]

  • 13. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y, Yang H, Huang Z, Tian S, Li Q, Du C, Chen T, Liu Y, Sun H, Liu Z.
    Molecules; 2020 Jan 23; 25(3):. PubMed ID: 31979317
    [Abstract] [Full Text] [Related]

  • 14. Spiropyrrolidine/spiroindolizino[6,7-b]indole heterocyclic hybrids: Stereoselective synthesis, cholinesterase inhibitory activity and their molecular docking study.
    Arumugam N, Almansour AI, Suresh Kumar R, Altaf M, Padmanaban R, Sureshbabu P, Angamuthu G, Kotresha D, Manohar TS, Venketesh S.
    Bioorg Chem; 2018 Sep 23; 79():64-71. PubMed ID: 29723743
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W, Sağlık BN, Levent S, Korkut B, Ilgın S, Özkay Y, Kaplancıklı ZA.
    Molecules; 2018 Aug 14; 23(8):. PubMed ID: 30110946
    [Abstract] [Full Text] [Related]

  • 16. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A, Krishnaraju V, Taha A, Kalpana K, Malarkodi V, Durgaramani S, Vinoth Prabhu V, Saleh FA, Ezhilarasan S.
    Eur Rev Med Pharmacol Sci; 2024 Mar 14; 28(6):2522-2537. PubMed ID: 38567612
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Tüylü Küçükkılınç T, Miri R, Edraki N.
    Bioorg Chem; 2019 Aug 14; 89():103006. PubMed ID: 31158577
    [Abstract] [Full Text] [Related]

  • 18. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A, de los Ríos C, Bolea I, Chioua M, Iriepa I, Moraleda I, Bartolini M, Andrisano V, Gálvez E, Valderas C, Unzeta M, Marco-Contelles J.
    Eur J Med Chem; 2012 Jun 14; 52():251-62. PubMed ID: 22503231
    [Abstract] [Full Text] [Related]

  • 19. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS, Khan SU, Ejaz SA, Afridi S, Rizvi SUF, Najam-Ul-Haq M, Iqbal J.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):615-624. PubMed ID: 27865835
    [Abstract] [Full Text] [Related]

  • 20. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T, Więckowska A, Więckowski K, Godyń J, Jończyk J, Valdivieso ÁDR, Panek D, Pasieka A, Sabaté R, Knez D, Gobec S, Malawska B.
    Eur J Med Chem; 2020 Feb 01; 187():111916. PubMed ID: 31812794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.